Media

VANCOUVER, British Columbia, April 18, 2019 (FSCwire) Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (US OTC; VIRFF) is pleased to announce that the Company will host a conference call on Thursday May 2, 2019 at 1:15PM PST / 4:15PM EST to provide a...

March 26, 2019: The Board of Directors of Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce the appointment of Ms. Kamini Hitkari to the position of Chief Financial Officer, commencing on March 26, 2019. Ms. Hitkari joins Viridium...

March 18, 2019: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to provide shareholders with the year end financials and a corporate update. Year End Viridium has now filed the year end consolidated financial statements and management discussion and analysis for...

March 7, 2019: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has commenced clone sales as starting materials.  Its first...

Viridium Pacific Group announced that it had entered into an amalgamation agreement with EFX Laboratories Inc. to acquire all issued and outstanding Class A common shares of EFX. Click here to download the presentation...

As cannabis is legalized across the country on Oct. 17, Global News is answering key questions on what it means for you: What will the roll out look like in each province? What’s the impact on the economy? On your health? To keep up to date...

(MENAFN Editorial) VANCOUVER, BC / ACCESSWIRE / October 15, 2018 / The Board of Directors of Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSX-V: VIR; OTC PINK: VIRFF) is pleased to announce the appointment of Mr. Jay Garnett to the position of President &...

October 11, 2018 — Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce that its wholly owned subsidiary, Experion Biotechnologies Inc. ("Experion"), has completed its second sale of dried medical cannabis to Emerald Health Therapeutics Canada Inc. ("Emerald")...